Opinion Bridgepoint sets three targets for RoC Skincare Antin wins regulatory approval for Opdenergy deal. Craig McGlashan - 21 February 2024 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in